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Abstract: OBJECTIVES This study sought to compare a new quantitative angiographic technique to
cardiac magnetic resonance-derived regurgitation fraction (CMR-RF) for the quantification of prosthetic
valve regurgitation (PVR) after transcatheter aortic valve replacement (TAVR). BACKGROUND PVR
after TAVR is challenging to quantify, especially during the procedure. METHODS Post-replacement
aortograms in 135 TAVR recipients were analyzed offline by videodensitometry to measure the ratio
of the time-resolved contrast density in the left ventricular outflow tract to that in the aortic root
(videodensitometric aortic regurgitation [VD-AR]). CMR was performed within an interval of ￿30 days
(11 ± 6 days) after the procedure. RESULTS The average CMR-RF was 6.7 ± 7.0% whereas the average
VD-AR was 7.0 ± 7.0%. The correlation between VD-AR and CMR-RF was substantial (r = 0.78, p
< 0.001). On receiver-operating characteristic curves, a VD-AR ￿10% corresponded to >mild PVR as
defined by CMR-RF (area under the curve: 0.94; p < 0.001; sensitivity 100%, specificity 83%), whereas a
VD-AR ￿25% corresponded to moderate-to-severe PVR (area under the curve: 0.99; p = 0.004; sensitivity
100%, specificity 98%). Intraobserver reproducibility was excellent for both techniques (for CMR-RF,
intraclass correlation coefficient: 0.91, p < 0.001; for VD-AR intraclass correlation coefficient: 0.93, p
< 0.001). The difference on rerating was -0.04 ± 7.9% for CMR-RF and -0.40 ± 6.8% for VD-AR.
CONCLUSIONS The angiographic VD-AR provides a surrogate assessment of PVR severity after TAVR
that correlates well with the CMR-RF.
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STRUCTURAL
A Novel Angiographic Quantiﬁcation
of Aortic Regurgitation After TAVR
Provides an Accurate Estimation of
Regurgitation Fraction Derived From
Cardiac Magnetic Resonance Imaging
Mohamed Abdel-Wahab, MD,a Mohammad Abdelghani, MD, MSC,b Yosuke Miyazaki, MD, PHD,c
Erik W. Holy, MD, PHD,a Constanze Merten, MD,a Dirk Zachow, MD,d Pim Tonino, MD, PHD,e
Marcel C.M. Rutten, PHD,f Frans N. van de Vosse, PHD,f Marie-Angele Morel, MSC,g Yoshinobu Onuma, MD, PHD,c,g
Patrick W. Serruys, MD, PHD,h Gert Richardt, MD, PHD,a Osama I. Soliman, MD, PHDc,g
ABSTRACT
OBJECTIVES This study sought to compare a new quantitative angiographic technique to cardiac magnetic
resonance-derived regurgitation fraction (CMR-RF) for the quantiﬁcation of prosthetic valve regurgitation (PVR) after
transcatheter aortic valve replacement (TAVR).
BACKGROUND PVR after TAVR is challenging to quantify, especially during the procedure.
METHODS Post-replacement aortograms in 135 TAVR recipients were analyzed ofﬂine by videodensitometry to
measure the ratio of the time-resolved contrast density in the left ventricular outﬂow tract to that in the aortic root
(videodensitometric aortic regurgitation [VD-AR]). CMR was performed within an interval of #30 days (11  6 days)
after the procedure.
RESULTS The average CMR-RF was 6.7  7.0% whereas the average VD-AR was 7.0  7.0%. The correlation between
VD-AR and CMR-RF was substantial (r ¼ 0.78, p < 0.001). On receiver-operating characteristic curves, a VD-AR $10%
corresponded to >mild PVR as deﬁned by CMR-RF (area under the curve: 0.94; p < 0.001; sensitivity 100%, speciﬁcity
83%), whereas a VD-AR $25% corresponded to moderate-to-severe PVR (area under the curve: 0.99; p ¼ 0.004;
sensitivity 100%, speciﬁcity 98%). Intraobserver reproducibility was excellent for both techniques (for CMR-RF,
intraclass correlation coefﬁcient: 0.91, p < 0.001; for VD-AR intraclass correlation coefﬁcient: 0.93, p < 0.001).
The difference on rerating was –0.04  7.9% for CMR-RF and –0.40  6.8% for VD-AR.
CONCLUSIONS The angiographic VD-AR provides a surrogate assessment of PVR severity after TAVR that correlates
well with the CMR-RF. (J Am Coll Cardiol Intv 2018;11:287–97) © 2018 by the American College of Cardiology Foundation.
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S ince the introduction of transcatheteraortic valve replacement (TAVR) as aminimally invasive alternative to sur-
gery (1), signiﬁcant improvements have been
introduced to this technology. Currently,
TAVR outperforms surgery in many aspects
(2), but prosthetic valve regurgitation (PVR)
still occurs at a higher rate than after surgery
and portends worse prognosis (3). The quanti-
ﬁcation of PVR is challenging (4). Although
long-term surveillance is typically based on
echocardiography, recent data support a
more reliable prognostic value of cardiac
magnetic resonance–derived regurgitation
fraction (CMR-RF) (5,6). This superior prog-
nostication is added to some other well-
known advantages of CMR over echocardiography,
including more reproducible and quantitative assess-
ment (4). CMR can, therefore, be considered as an
ideal tool to quantify PVR but is limited by a number
of logistic constraints. The high cost, limited availabil-
ity, technical demand, and incompatibility with
some implanted cardiac rhythm devices all make
CMR a less practical tool for routine PVR assessment
compared with echocardiography (4).
Recently, the minimalist TAVR approach is
increasingly adopted by large TAVR centers. In this
approach, general anesthesia is replaced by sedation
and transesophageal echocardiography is seldom an
option. In this setting, angiographic assessment,
which currently serves as the ﬁrst screening tool in
most laboratories, is becoming even more crucial in
determining the severity of PVR during the proced-
ure. Angiographic assessment using the classic
visual (Sellers’) method (7) bears many limitations,
including subjectivity and lack of precise quantiﬁca-
tion (4). Quantitative videodensitometric aortic
regurgitation (VD-AR) assessment was recently re-
ported to overcome the limitations of the Sellers’
method (4,8,9). In this study, we sought to compare
2 quantitative modalities for PVR assessment; a well-
established modality that cannot be used in the cath
lab (CMR-RF) and a novel one which has the potential
to be applied in the cath lab for PVR quantiﬁcation
and decision-making guidance (VD-AR). The primary
objective was to estimate the correlation between
these 2 modalities, whereas the secondary objective
was to compare their reproducibility.
METHODS
STUDY POPULATION. All patients who were treated
with TAVR and had a CMR study performed after the
procedure at the Heart Center, Segeberger Kliniken
GmbH (Bad Segeberg, Germany), were screened for
inclusion in this study. The ﬂow chart of the study is
displayed in Online Figure 1. The main reason for
exclusion was VD-AR nonanalyzability (principally
due to overlap of the regions of interest by the
contrast-ﬁlled descending aorta [83%] or breathing
motions [9%]). A total of 135 consecutive patients
treated with TAVR who had quantitative angiographic
and CMR assessments of PVR performed within an
interval of #30 days constituted the study popula-
tion. Data collection was approved by the institu-
tional review board, and all patients signed a written
informed consent.
QUANTITATIVE AORTIC ROOT ANGIOGRAPHY USING
VIDEODENSITOMETRY. Aortic root angiography was
performed after valve replacement using a nonionic
contrast (25 to 30 ml) injected through a pigtail
catheter positioned above the prosthetic valve (in
case of a balloon- or mechanically-expandable device)
or within the distal third of the prosthetic valve (in
case of a self-expanding device). A dedicated soft-
ware (CAAS A-Valve 2.0.2, Pie Medical Imaging,
Maastricht, the Netherlands) was used for ofﬂine
analysis of the angiograms. The details of this tech-
nique have been described elsewhere (9,10). Brieﬂy,
the aortic root and the subaortic (basal) one-third of
the left ventricle (LV) are manually traced, and the
aortic valve annular plane is indicated to deﬁne the
distal end of the LV region of interest. Contrast time-
density curves are generated for both the region of
interest (in the LV) and the reference region (the
aortic root) from at least 3 cardiac cycles after contrast
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injection. From these time-density curves, the area
under the curve (AUC) is automatically calculated to
represent the time-density integral. VD-AR corre-
sponds to the relative AUC, which is automatically
calculated by dividing the AUC of the LV region of
interest by the AUC of the aortic root (Figure 1). VD-AR
was analyzed by an independent core laboratory
(Cardialysis Clinical Trials Management and Core
FIGURE 1 Quantitative Assessment of Prosthetic Valve Regurgitation by Videodensitometric Aortography and CMR
(Top, left) A post–transcatheter aortic valve replacement aortogram with videodensitometric analysis. A color-weighted contrast time-density
map is superimposed on the subaortic segment of the ventricle, whereas the reference region (aortic root) is highlighted with red color. (Top,
right) Steady-state free precession cardiac magnetic resonance (CMR) image (yellow dotted line¼ imaging plane for velocity mapping). (Middle
and Bottom) Two examples of post–transcatheter aortic valve replacement patients with mild and moderate-to-severe prosthetic valve
regurgitation. On videodensitometric angiographic analysis (left), the area under the contrast time-density curve of the left ventricular outﬂow
tract (yellow) is divided by that of the aortic root (red) to yield videodensitometric aortic regurgitation (AR). On CMR (right), the backward ﬂow
(below the baseline) is divided by the forward ﬂow (above the baseline) to yield the regurgitation fraction (RF) (CMR-RF).
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Laboratories, Rotterdam, the Netherlands) and
observers were blinded to all baseline, procedural,
and CMR data. Rerating by the same observer was
performed in 75 cases to test the intrinsic variability
of the method.
CMR IMAGING PROTOCOL AND DATA ANALYSIS.
All patients were investigated by electrocardiogram-
gated CMR in the supine position with a 5-element
cardiac phased-array coil using a 1.5-T whole-body
scanner (Magnetom Espree, Siemens AG, Erlangen,
Germany). The ﬂow signal at the level of the stent of
the prosthetic valve could be safely interrogated by
CMR as previously described (11,12).
For ﬂow measurements, a breath-hold velocity-
encoded phase contrast magnetic resonance
sequence was used (“through plane,” segmented
fast low-angle shot 2-dimensional sequence, repeti-
tion time ¼ 46.0 ms, echo time ¼ 2.7 ms, velocity
encoding ¼ 150 to 300 cm/s–1, scan in expiration,
scan duration around 10 s). The slice was positioned
perpendicular to the long axis of the ascending aorta
closely beneath the upper margin of the stent of
self-expanding prostheses or at a corresponding
distance from the aortic annulus for all other shorter
TAVR prostheses. This position was chosen as it had
been proven to be less susceptible to artifacts
caused by the valve and stent compared with a
lower position, and a perpendicular cut through the
ascending aorta could be achieved more accurately.
In fact, no visible artifacts of the valve or the stent
were seen on the analyzed images. Contrast
administration was not necessary for both cine im-
aging and ﬂow measurements. Consequently, no
patients were excluded because of impaired renal
function.
CMR data were analyzed by 2 independent and
experienced observers. No formal blinding was per-
formed, but observers had no access to the results of
echocardiography or angiography data at the time of
CMR evaluation. Rerating by the same observer was
performed in 75 randomly elected cases to test the
intrinsic variability of the method.
For the assessment of the aortic RF, the cross-
sectional area of the ascending aorta was deﬁned
and manually corrected for motion artifacts that
occurred during the breath hold scan. Using a stan-
dard software (Argus WIP 2.3, Siemens AG, Erlangen,
Germany), the forward and reverse volumes within
this region of interest were determined, and the RF
was calculated as follows: (regurgitant volume/total
forward volume)  100 (Figure 1). CMR-RF of #15%
was graded as trace-mild and >30% was graded as
moderate-to-severe PVR according to criteria used in
previous TAVR studies (11–13).
STATISTICS. When nonparametric statistical methods
were used, we summarized data as median (inter-
quartile range) instead of mean  SD. Categorical
variables were summarized as frequencies and per-
centages. The distribution of CMR-RF and VD-AR
across the angiographic visual Sellers’ grades was
compared using Mann–Whitney U test. The relation-
ship between continuous parameters of AR severity
was tested using Pearson correlation whereas the
relation between quantitative and qualitative param-
eters was tested using Spearman correlation. For the
correlation between VD-AR and CMR-RF, the sample
size was estimated to be at least 19 data pairs (for a
level of 0.05, a b level of 0.20 [power ¼ 80%], and a
hypothesized correlation coefﬁcient r ¼ 0.60 [denot-
ing at least moderate correlation]). Fisher r-to-z
transformation was used to assess the signiﬁcance of
the difference between 2 correlation coefﬁcients.
Receiver-operating characteristic curves were gener-
ated for the VD-AR values that correspond to mild and
moderate-to-severe PVR as deﬁned by CMR-RF. The
area under the receiver-operating characteristic
curve was calculated and the cutpoints were deﬁned
on the basis of the highest sum of sensitivity and
speciﬁcity. The reproducibility of CMR-RF and VD-AR
was assessed by calculating the intraclass correlation
coefﬁcient presented with its 95% conﬁdence interval
(CI). The difference on rerating was displayed using
the Bland-Altman method and the 95% limits of
agreement were estimated as  1.96  SD of the dif-
ference. Statistical analysis was performed with SPSS
version 23 (IBM Corporation, Armonk, New York). All
probability values were 2 tailed, and a value of p<0.05
was considered statistically signiﬁcant.
RESULTS
The study included 135 patients who underwent
TAVR principally through a transfemoral approach
(97.0%) and were treated either with a balloon-
expandable (60.5%), self-expanding (32.0%), or me-
chanically expanding (7.5%) bioprosthesis. The
baseline characteristics of the study population are
summarized in Table 1.
ASSESSMENT OF PVR. PVR severity was assessed by
procedural angiography and by CMR performed
within 30 days (11  6 days) after the procedure.
During CMR, 83 patients (62%) were in sinus rhythm
with an average heart rate of 67  12 beats/min.
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The remainder had atrial ﬁbrillation with an average
heart rate of 69  12 beats/min. The average CMR-RF
was (6.7  7.0%; median 4.7% [interquartile range:
1.6% to 9.2%]) whereas the average VD-AR was
(7.0  7.0%; 5.0% [interquartile range: 2.0% to
9.0%]). Online Figure 2 displays the cumulative
curves of PVR severity as assessed by both tech-
niques. On pre-discharge transthoracic echocardiog-
raphy, PVR was graded as none or trace in 77 patients
(57%), as mild in 54 patients (40%), and as moderate
in 4 patients (3%).
QUANTITATIVE VERSUS QUALITATIVE ASSESSMENT
OF PVR BY CMR AND ANGIOGRAPHY. The visual
(Sellers’) grades of PVR severity on post-implantation
angiography were none (Sellers’ 0) in 39 patients
(28.9%), mild (Sellers’ I) in 74 patients (54.8%),
moderate (Sellers’ II) in 15 patients (11.1%), and
moderate-to-severe (Sellers’ III) in 8 patients (5.9%).
The distributions of CMR-RF and VD-AR across the
Sellers’ grades are shown in Figures 2A and 2B.
Spearman’s coefﬁcient of correlation between Sellers’
grades and CMR-RF was 0.25 and between Sellers’
grades and VD-AR was 0.55 (p < 0.001).
INTERMODALITY AGREEMENT IN THE QUANTITATIVE
ASSESSMENT OF PVR. The correlation between VD-AR
and CMR-RF was substantial (Pearson r ¼ 0.78;
p < 0.001) (Figure 3). The correlation remained sig-
niﬁcant in the following patient subgroups: patients
with atrial ﬁbrillation (n ¼ 52; r ¼ 0.77), patients who
received a self-expanding device (n ¼ 42; r ¼ 0.86),
patients in whom balloon post-dilatation was per-
formed (n ¼ 24; r ¼ 0.82), and patients in whom
aortographic acquisition projection was LAO (n ¼ 96;
r ¼ 0.73; p < 0.001 for all).
On receiver-operating characteristic curves, a
VD-AR $10% corresponded to >mild PVR as deﬁned
by CMR-RF (AUC: 0.94; 95% CI: 0.90 to 0.98; p<0.001;
sensitivity: 100%; speciﬁcity: 83%), whereas a
VD-AR $25% corresponded to moderate-to-severe
PVR (AUC: 0.99; 95% CI: 0.98 to 1.00; p ¼ 0.004;
sensitivity: 100%; speciﬁcity: 98%).
REPRODUCIBILITY OF THE 2 QUANTITATIVE TECHNIQUES
OF PVR ASSESSMENT. To investigate the inherent
variability of the method, CMR-RF was rerated by the
same analyst in the same session in 75 randomly
selected cases. The intraclass correlation coefﬁcient
was 0.91 (95% CI: 0.86 to 0.95; p < 0.001). As shown
in Online Figure 3A, the average bias on rerating
was 0.04% whereas the 95% limits of agreement
were 7.9%.
In Online Figure 4, patient-dots were labeled to
indicate the cardiac rhythm (atrial ﬁbrillation vs. sinus
rhythm) during CMR acquisition. The average bias
was similar regardless of the cardiac rhythm, but
the limits of agreement were wider apart in patients
with atrial ﬁbrillation (10.6%) than in patients in
sinus rhythm (6.7%).
VD-AR was also rerated by the same analyst in the
same 75 cases. The intraclass correlation coefﬁcient
was 0.93 (95% CI: 0.88 to 0.95; p < 0.001). As shown
in Online Figure 3B, the average bias on rerating was
0.40% and the 95% limits of agreement were 6.8%.
DISCUSSION
In the present study, VD-AR was shown to provide a
surrogate assessment of the regurgitant fraction (as
deﬁned by CMR) with a comparable reproducibility.
Therefore, VD-AR has a 2-fold advantage: 1) it is
angiography based, and hence is available in all
procedures; and 2) it provides a reproducible
quantitative assessment of PVR severity.
TABLE 1 Baseline Characteristics of the Study Population (n ¼ 135)
Age, yrs 81  6
Male 57 (42)
BMI, kg/m2 27  5
Logistic EuroSCORE 23.2  16.7
STS score 6.2  6.7
Hypertension 125 (93)
Diabetes mellitus 36 (27)
Dyslipidemia 68 (50)
NYHA functional class III–IV 88 (65)
Atrial ﬁbrillation 52 (39)
Chronic obstructive pulmonary disease 20 (15)
Coronary artery disease 93 (69)
Previous PCI 48 (36)
Previous CABG 28 (21)
Previous SAVR 8 (6)
Cerebrovascular disease 20 (15)
Peripheral arterial disease 20 (15)
Chronic kidney disease 30 (22)
LV ejection fraction, % 54  13
Transaortic valve mean PG, mm Hg 44  18
Aortic valve area, cm2 0.64  0.28
Aortic annulus diameter (on TEE), mm 23.1  2.2
sPAP, mm Hg 46.5  15.9
Mitral regurgitation, moderate-severe 34 (25)
Aortic regurgitation, moderate-severe 23 (17)
Values are mean  SD or n (%).
BMI ¼ body mass index; CABG ¼ coronary artery bypass grafting; LV ¼ left
ventricle; NYHA ¼ New York Heart Association; PCI ¼ percutaneous coronary
intervention; PG ¼ pressure gradient; SAVR ¼ surgical aortic valve replacement;
sPAP ¼ systolic pulmonary artery pressure; STS ¼ Society of Thoracic Surgeons;
TEE ¼ transesophageal echocardiography.
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VD-AR has been shown to be feasible (10) and repro-
ducible (9,10) and to correlate with echocardiographic
assessment (8) and with clinical outcomes (8,9).
Additionally, in an in vitro validation (n ¼ 29 obser-
vations) in a PVR model of a balloon-expandable de-
vice implanted in a mock circulation system (14–16),
VD-AR was shown to closely correlate (r2 ¼ 0.964;
y ¼ 0.816x  3.049) with the regurgitation fraction
measured by a transonic ﬂow probe. In the present
study, in vivo accuracy and precision of this technique
were further conﬁrmed.
The incidence of PVR after TAVR has dramatically
improved thanks to improved valve design and size
range and, most importantly, to proper sizing (4).
However, the incidence of mild PVR remains high—
albeit with controversial prognostic relevance
(17–20)—and the extension of TAVR indications to pa-
tients with bicuspid or predominantly-regurgitant
aortic valves is expected to increase the potential for
PVR (4). PVR remains, therefore, an important limita-
tion of TAVR as compared with surgery and its timely
detection, accurate quantiﬁcation, and effective
elimination remain of crucial importance. For this
target to be achieved, a reliable intraprocedural tool to
detect and quantify PVR is required. Transesophageal
echocardiography, which has long been the standard
intraprocedural tool for PVR assessment, is now
progressively less utilized in the era of “minimalist
TAVR” (21). Although transthoracic echocardiography
was reported to be an efﬁcient alternative for proce-
dural guidance (22), its intraprocedural use is compli-
cated by important technical constraints (23). The
invasivelymeasured AR indexwas shown to deﬁne the
severity of PVR and an AR index of <25 correlated with
clinical outcome after TAVR (24). However, the speci-
ﬁcity of AR index is modest and an AR index of <25
often coexists with no or trivial AR, particularly in the
presence of relative bradycardia (25).
Aortic root angiography is the ﬁrst screening tool
for PVR in most laboratories and is a quick and
friendly tool to the interventionists. However, the
visual (Sellers’) assessment is subjective, qualitative,
and nonvalidated in the post-TAVR setting (4). It
has been previously reported that native aortic
valve regurgitation volume and fraction measured
by magnetic ﬂowmetry (26) and by cardiac catheteri-
zation (using Fick’s method and left ventriculog-
raphy) (27–29) markedly overlap between the Sellers’
grades. In the setting of TAVR, comparison of the
Sellers’ grades with PVR volume and fraction
revealed that there is only a moderate correlation
with a signiﬁcant overlap between the Sellers’ grades
and PVR volume or fraction (30). In the present study,
this overlap was further conﬁrmed (Figures 2A and 2B).
FIGURE 2 Distribution of CMR-RF and Videodensitometric AR Across the Angiographic Sellers’ Grades of Prosthetic Valve Regurgitation
Severity
(A) There has been an overlap between cardiac magnetic resonance–derived regurgitation fraction (CMR-RF) and Sellers’ grades of aortic
regurgitation (AR), especially between Sellers’ 0 and Sellers’ I (p > 0.05). (B) The overlap between videodensitometric AR and Sellers’ grades
was less remarkable.
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IMPLEMENTATION OF THE VD-AR TECHNOLOGY
INTO ROUTINE CLINICAL PRACTICE. There are
currently 3 main issues that need to be dealt with, to
allow for the routine use of VD-AR (Figure 4). First,
the limited analyzability rate, ranging from 43% (in
the present study) to 65% and 68% (in previous
studies) (8,9), is a major shortcoming of this new
angiographic technique when applied retrospec-
tively to aortograms that have not been acquired
following a standardized acquisition protocol. The
limited yield is principally (>90%) due to technical
operator-dependent factors, mostly involving an
overlap of the contrast-ﬁlled descending aorta on the
LV outﬂow tract or aortic root (Figure 4A) (31). The
deﬁnition of a patient-speciﬁc overlap-free ﬂuoro-
scopic projection is now possible, thanks to computed
tomographic planning, and is reliable in 98% of cases
(32). As shown in Figures 4B and 4C, an overlap-free
projection can be predicted using computed tomog-
raphy well in advance of the procedure. An alterna-
tive simpliﬁed rule is to choose an angulation of $35
to 40 toward the same side as the descending aorta
relative to a vertical line that hemisects a diagonal
line extending from LV apex to the ascending aorta
(Figures 4D and 4E).
Second, one further step to optimize the accuracy
and reproducibility of the results of this new tech-
nique, is angiographic acquisition standardization.
This includes standardization of the volume, rate,
and timing of contrast injection as well as the position
of the catheter tip. Based on an in vitro validation
model, injection of 20 ml of contrast at a rate of
20 ml/s with the catheter tip positioned #20 mm
above the aortic (prosthetic) valve leaﬂets seems to
provide excellent accuracy and reproducibility (16). A
short diastolic injection synchronized to an electro-
cardiographic trigger can also help reduce the
contrast volume to 8 ml per injection (16). Due to the
observation seen in some TAVR cases, that PVR shows
a marked improvement within few minutes after
valve implantation (likely due to the interaction of
the external sealing skirt with the landing zone,
which probably needs few minutes to be established),
it is recommended to delay the ﬁnal aortographic
acquisition to 10 min after ﬁnal valve deployment. It
is also important not to overlook the inﬂuence of
“Automatic Exposure Control” characteristic built
into most of angiographic acquisition systems. This
mode implies a dynamic adjustment of the x-ray
exposure, and hence change of pixel darkness, to
maintain a constant image quality at the expense of
oscillating brightness. Such a property can inﬂuence
the automatic VD assessment of contrast density, and
should thus be inactivated when VD assessment is
intended.
Third, enabling a real-time online use of VD-AR
within the cath lab helps guide the decision making
as whether a corrective measure is required and
judging its effectiveness. Currently, ofﬂine analysis
entails a manual contour tracing. Although this
tracing typically requires <1 min, it can be made even
faster and more reproducible through the overlay of
the pre-loaded computed tomographic contours of
the heart and aortic root on the ﬂuoroscopic images.
This can potentially enable instant analysis of VD-AR
within few seconds, instead of the current method,
which requires, on average, 3 min per analysis.
A feasibility study of the online implementation of
the technology is currently underway with the results
being anticipated in 2018 (31). Figure 4 summarizes
the current technical limitations of the technology
and the respective ongoing or proposed solutions to
help its clinical implementation.
Overall, one intrinsic limitation of aortography in
assessing PVR, is the inability to discriminate trans-
valvular from paravalvular regurgitation. Although
signiﬁcant post-TAVR PVR is often paravalvular,
conﬁrmation of the mechanism of regurgitation is still
important before performing a corrective maneuver
FIGURE 3 Linear Correlation Between CMR-RF and Videodensitometric AR
The scatter plot shows that the linear relationship is weaker at the lower CMR-RF values
(<5%). Abbreviations as in Figure 2.
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FIGURE 4 Technical Limitations of Videodensitometric AR and the Respective Practical Solutions
The 3 major technical limitations of videodensitometric AR technology are listed in the left-hand side column and their respective ongoing or proposed solutions listed in the
respective cells of the right-hand side column. The limited yield (analyzability) is principally due to (A) an overlap of the contrast ﬁlled descending aorta on the regions of
interest. (B, C) An overlap free-projection can be predicted using baseline computed tomography. (D, E) Another option to get an overlap-free projection has been proposed by
Teng et al. (32): the posterior-anterior projection on ﬂuoroscopy (middle) and on computed tomography (top) as well as an overlap-free ﬂuoroscopic projection (bottom) of 2
patients (D, E) are shown. A diagonal green line extending from the left ventricular apex to ascending aorta is hemisected by a blue vertical line. The catheter path in the
descending aorta is indicated by the white arrows. (D) The descending aorta is predominantly to the left side of the blue line, and an LAO 35 projection was overlap-free. (E)
The descending aorta is predominantly on the right side of the blue line, and an RAO 34 projection was overlap-free. (F) The main elements of a standardized aortographic
acquisition protocol to improve accuracy and reproducibility of videodensitometric AR. Figure G shows how the integration of the videodensitometric AR technology into an
on-line workﬂow in the cath lab can be helped by the HeartNavigator technology (Philips Healthcare, Eindhoven, the Netherlands) to impose the cardiac contours over the
ﬂuoroscopic images precluding the need for manual tracing. Adapted with permission from Sahyoun (31) and Teng et al. (32).
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(e.g., post-dilatation). Therefore, in selective cases
where VD-AR reveals a signiﬁcant regurgitation, an
ad hoc echocardiographic conﬁrmation of a para-
valvular mechanism of regurgitation before a correc-
tive measure is undertaken is reasonable.
It should also be noted that the increasing reliance
on aortography in procedural guidance will require
the use of a larger volume of contrast medium with
the potential to increase the risk of acute kidney
injury. This caveat calls even more for complimentary
roles of VD-AR and echocardiography. The higher
sensitivity of videodensitometry in detecting contrast
density, as compared with visual assessment, enabled
the introduction of a novel contrast-sparing syn-
chronized (diastolic-only) aortographic injection
technique. The latter has been tested in an in vitro
setting, and enabled the reduction of the contrast
volume from 20 ml to 8 ml per injection without
compromising diagnostic accuracy (16).
Finally, it is important to establish a VD-AR cut-
point that deﬁnes device success and the need for—
and the efﬁcacy of—a corrective measure. Although a
VD-AR of $25% corresponded to moderate-severe AR
as deﬁned by CMR in the present study, current evi-
dence (8,9,33) suggests that even lower VD-AR values
(>17%) correspond to a “clinically-relevant” PVR.
CMR-RFASAREFERENCESTANDARD. Echocardiographic
criteria of PVR severity, although advocated by the
Valve Academic Research Consortium, are not
adequately validated (34). Additionally, the repro-
ducibility of these criteria is limited (35), and can be
improved through an approach that combines quali-
tative and semi-quantitative but not quantitative
parameters (36). Although not without limitations (4),
CMR-RF is a reliable measure of PVR severity, and
outperforms echocardiography in predicting clinical
outcomes in patients with native (6) and prosthetic
(5) AR. Moreover, like angiography, accuracy of
CMR is less inﬂuenced by the number and eccentric-
ity of the paravalvular leaks than echocardiography.
Therefore, we used CMR-RF as a reference standard
in the present study. It should be noted, however,
that the diagnostic accuracy of CMR-RF is lower in
mild AR (4). CMR-RF was not signiﬁcantly different in
patients with mild AR (as deﬁned by echocardiogra-
phy) than in healthy subjects in some studies (37,38).
The closing volume (3.3  1.2 ml per beat) (39) and the
coronary ﬂow (1.5 ml to 3.0 ml per beat in average)
(40) are possible explanations of this phenomenon. It
is also worth-mentioning that there is no consensus
on the CMR-RF cutpoints of AR severity (4), and that
the cutpoints used in this study are not well estab-
lished. In the setting of TAVR, the underlying LV is
hypertrophied with a small cavity and stroke volume.
Therefore, a relatively small absolute regurgitation
volume might correspond to a large regurgitation
fraction (18). Accordingly, regurgitation fraction is
likely more reliable in the setting of TAVR than
regurgitation volume to reﬂect the actual severity of
PVR. Additionally, the concept of the relative AUC on
videodensitometry is more in line with the fraction—
than the absolute volume—of regurgitation.
STUDY LIMITATIONS. An interval of 30 days
(average ¼ 11 days) between angiography and CMR
was allowed and changes of blood pressure and heart
rate might have inﬂuenced the assessment of AR
severity between the 2 time points. Therefore, the
correlation between both methods might have been
stronger if both techniques were performed in the
same day. However, this ideal scenario is impractical
for a TAVR patient.
The regions of interest were drawn manually and
this might have introduced some variability to the
measurements. However, this effect seems to be mi-
nor as evidenced by the excellent reproducibility on
repeat assessment. Efforts to make this process
automated using co-registration with baseline
computed tomographic images are underway.
CONCLUSIONS
The present study aimed at comparing a novel tool to
a well-established tool of PVR quantiﬁcation. The
novel tool (VD-AR) provides a surrogate assessment
of PVR after TAVR that correlated well with the CMR-
RF. Moreover, the reproducibility of VD-AR is very
much the same as that of CMR-RF.
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